Best Buy Co., Inc.
US ˙ NYSE ˙ US0865161014

SecurityBBY / Best Buy Co., Inc.
InstitutionEmpowered Funds, LLC
Latest Disclosed Ownership197,017 shares
Latest Disclosed Value $ 12,648,492
Empowered Funds, LLC ownership in BBY / Best Buy Co., Inc.

On May 15, 2026 - Empowered Funds, LLC filed a 13F-HR form disclosing ownership of 197,017 shares of Best Buy Co., Inc. (US:BBY) valued at $12,648,491 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 58,711 shares of Best Buy Co., Inc.. This represents a change in shares of 235.57% during the quarter. The current value of the position is $14,132,029 USD.

Empowered Funds, LLC has a history of taking positions in derivatives of the underlying security (BBY) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BBY / Best Buy Co., Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BEST BUY COM 086516101 197,017 138,306 235.57 12,648 221.91 0.0354
2026-02-11 2025-12-31 13F BEST BUY COM 086516101 58,711 47,557 426.37 3,930 366.07 0.0313
2025-11-13 2025-09-30 13F BEST BUY COM 086516101 11,154 -49,312 -81.55 843 -79.23 0.0085
2025-08-11 2025-06-30 13F BEST BUY COM 086516101 60,466 218 0.36 4,059 -8.46 0.0459
2025-05-16 2025-03-31 13F BEST BUY COM 086516101 60,248 -58,893 -49.43 4,435 -56.62 0.0631
2025-01-28 2024-12-31 13F BEST BUY COM 086516101 119,141 90,247 312.34 10,222 242.56 0.1494
2024-11-06 2024-09-30 13F BEST BUY COM 086516101 28,894 -12,910 -30.88 2,985 -15.30 0.0469
2024-07-30 2024-06-30 13F BEST BUY COM 086516101 41,804 -77,327 -64.91 3,524 -63.95 0.0610
2024-05-07 2024-03-31 13F/A-1 BEST BUY COM 086516101 119,131 11,144 10.32 9,772 15.60 0.1764
2024-05-06 2024-03-31 13F BEST BUY COM 086516101 119,131 11,144 9,772 0.0844
2024-02-14 2023-12-31 13F BEST BUY COM 086516101 107,987 92,493 596.96 8,453 685.59 0.2122
2023-11-01 2023-09-30 13F BEST BUY COM 086516101 15,494 12,787 472.37 1,076 386.88 0.0317
2023-07-27 2023-06-30 13F BEST BUY COM 086516101 2,707 -12,283 -81.94 222 -81.16 0.0078
2023-04-05 2023-03-31 13F BENITEC BIOPHARMA PUT 086516101 0 -33,018 -100.00 0 -100.00
2023-04-05 2023-03-31 13F BEST BUY COM 086516101 14,990 -18,028 -54.60 1,173 -55.70 0.0692
2023-02-21 2022-12-31 13F/A-1 BENITEC BIOPHARMA PUT 086516101 33,018 33,018 2,648 0.1731
2023-01-26 2022-12-31 13F BENITEC BIOPHARMA PUT 086516101 33,018 33,018 3 0.1731
2022-08-01 2022-06-30 13F BEST BUY COM 086516101 0 -7,794 -100.00 0 -100.00
2022-04-21 2022-03-31 13F BEST BUY COM 086516101 7,794 -45,610 -85.41 708 -86.95 0.0774
2022-02-10 2021-12-31 13F BEST BUY COM 086516101 53,404 8,453 18.80 5,426 14.18 0.6119
2021-11-12 2021-09-30 13F BEST BUY COM 086516101 44,951 5,519 14.00 4,752 4.83 0.6097
2021-11-12 2021-06-30 13F/A-1 BEST BUY COM 086516101 39,432 12,201 44.81 4,533 66.84 0.5755
2021-08-04 2021-06-30 13F BEST BUY COM 086516101 39,432 12,201 4,534 0.5756
2021-05-13 2021-03-31 13F BEST BUY COM 086516101 27,231 0 0.00 2,717 0.00 0.5205
2021-02-02 2020-12-31 13F BEST BUY COM 086516101 27,231 1,005 3.83 2,717 -6.92 0.5205
2020-10-26 2020-09-30 13F BEST BUY COM 086516101 26,226 26,226 2,919 0.9112
2020-07-16 2020-06-30 13F BEST BUY COM 086516101 0 -26,532 -100.00 0 -100.00
2020-04-16 2020-03-31 13F BEST BUY COM 086516101 26,532 26,532 1,512 0.8721
2020-01-27 2019-12-31 13F BEST BUY COM 086516101 0 -33,721 -100.00 0 -100.00
2019-11-01 2019-09-30 13F BEST BUY COM 086516101 33,721 -59 -0.17 2,326 -1.23 1.0125
2019-07-09 2019-06-30 13F BEST BUY COM 086516101 33,780 -4,324 -11.35 2,355 -13.04 0.9843
2019-05-10 2019-03-31 13F BEST BUY COM 086516101 38,104 103 0.27 2,708 34.53 0.9682
2019-01-22 2018-12-31 13F BEST BUY COM 086516101 38,001 -1,794 -4.51 2,013 -35.36 0.8517
2018-10-18 2018-09-30 13F BEST BUY COM 086516101 39,795 -2,869 -6.72 3,114 -2.66 0.9219
2018-07-09 2018-06-30 13F BEST BUY COM 086516101 42,664 -16,674 -28.10 3,199 -21.36 1.0092
2018-04-25 2018-03-31 13F BEST BUY COM 086516101 59,338 22,418 60.72 4,068 60.92 1.4851
2018-07-09 2017-12-31 13F/A-1 BEST BUY COM 086516101 36,920 4,847 15.11 2,528 38.37 1.2682
2018-07-09 2017-09-30 13F/A-1 BEST BUY COM 086516101 32,073 4,684 17.10 1,827 16.37 1.1856
2018-07-09 2017-06-30 13F/A-1 BEST BUY COM 086516101 27,389 -7,375 -21.21 1,570 -8.13 1.2731
2018-07-09 2017-03-31 13F/A-1 BEST BUY COM 086516101 34,764 34,764 1,709 1.7512
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-04-05 2023-03-31 13F BENITEC BIOPHARMA PUT 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-21 2022-12-31 13F/A BENITEC BIOPHARMA PUT 33,018 2,648 n/a n/a n/a
2023-01-26 2022-12-31 13F BENITEC BIOPHARMA PUT 33,018 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.